Skip to main content
HR 2920 115th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Alternative treatments Department of Health and Human Services Department of Veterans Affairs Drug trafficking and controlled substances Drug, alcohol, tobacco use Government employee pay, benefits, personnel management Health information and medical records Health personnel Licensing and registrations Medical research Research administration and funding State and local government operations Veterans' medical care

CARERS Act of 2017

Introduced: June 15, 2017 Introduced by: Cohen, Steve Democratic · Tennessee See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 16, 2017
Referred to the Subcommittee on Health.
Jun 15, 2017
Referred to the Subcommittee on Health.
Jun 15, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jun 15, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 15, 2017
Sponsor introductory remarks on measure. (CR E834)
Jun 15, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Compassionate Access, Research Expansion, and Respect States Act of 2017 or the CARERS Act of 2017

This bill amends the Controlled Substances Act to provide that the Act's regulatory controls and administrative, civil, and criminal penalties do not apply to a person who produces, possesses, distributes, dispenses, administers, tests, recommends, or delivers medical marijuana in compliance with state law.

The bill also:

  • excludes "cannabidiol" (CBD) from the definition of "marijuana";
  • limits the concentration of delta-9-tetrahydrocannabinol (THC) in CBD to 0.3 percent on a dry weight basis; and
  • deems marijuana grown or processed to make CBD, in accordance with state law, to comply with the THC concentration limit unless the Drug Enforcement Administration (DEA) determines state law to be unreasonable.

The bill directs the Department of Health and Human Services (HHS) to terminate the Public Health Service's interdisciplinary review process that is used to evaluate applications for medical marijuana research. The DEA must license manufacturers and distributors of marijuana for medical research; HHS must register practitioners to conduct research; and the Department of Veterans Affairs (VA) must authorize VA health care providers to provide recommendations and opinions to veterans regarding participation in their states' marijuana programs.

What's happening now June 16, 2017

Referred to the Subcommittee on Health.

 Committees of jurisdiction 6
 Cosponsors 9
All 9 Democratic 7 Republican 2